Bossi M, Matta F
G Ital Cardiol. 1987 Jan;17(1):45-56.
Within the multicentre trial of the Italian Group for the Study of Streptokinase in Infarct (G.I.S.S.I.), a particular study was planned for the analysis of plasma creatine kinase curves (CK). Serial measurements of total plasma CK from 11,806 pts (5.905 treated with Streptokinase (SK) and 5,901 control pts (C)) were evaluated by the compartment method (Fig. 7), which is commonly used in pharmacological studies. By this method, the plasma enzyme curve is interpreted on the basis of the following kinetic parameters: the fractional rate of input (Ki) and of disappearance (Kd) of enzyme into and from the blood; the plasma cumulative CK activity (Dp); the time interval between the onset of symptoms and the beginning of the ascending CK curve (To); the time from To to the peak CK (Tp). The Dp/Ki ratio was employed for the estimate of myocardial infarct size. From the available data, acceptable CK curves could be derived in 7,632 cases (3,568 treated with SK, 4,064 control pts.). Compared with control group (Fig. 1--Tab. I) the SK treated pts presented increased Ki and Kd values and reduced To, (p greater than 0.001), Dp/Ki (p greater than 0.05). The earlier SK treatment was started, the higher difference (Fig. 2) was observed between the two groups (SK and C). No significant difference was found between the two groups (SK and C) with regard to sex (Fig. 3), age, history of previous myocardial infarct, re-infarction, early post-infarction angina. Statistically significant similar differences of the above parameters between SK and C groups, were also found when various infarct locations were considered, with the only exception of not-Q infarct (Fig. 4). In the cases complicated by pericarditis (Tab. II, Fig. 5), independently of treatment, reduced reperfusion related indexes and increased Dp/Ki ratio were observed. Severe left ventricular impairment (Killip class 4) tends to reduce (Tab. III) the differences in enzyme parameters between the two groups (SK and C). The patients who died (18 hours after the onset of symptoms) exhibited as the only significant difference compared to survivors the infarct-size related CK parameters (Dp/Ki), independently from the treatment. The mathematical model used in this study proved to be easily feasible and useful for the evaluation of the effect of the treatment in acute myocardial infarct.(ABSTRACT TRUNCATED AT 400 WORDS)
在意大利链激酶治疗心肌梗死研究组(G.I.S.S.I.)的多中心试验中,计划进行一项专门研究以分析血浆肌酸激酶曲线(CK)。通过药理学研究中常用的房室模型法(图7),对11806例患者(5905例接受链激酶(SK)治疗,5901例为对照患者(C))的血浆总CK进行了系列测量。通过该方法,根据以下动力学参数解释血浆酶曲线:酶进入和离开血液的输入分数速率(Ki)和消失分数速率(Kd);血浆累积CK活性(Dp);症状发作与CK曲线上升开始之间的时间间隔(To);从To到CK峰值的时间(Tp)。Dp/Ki比值用于估计心肌梗死面积。根据现有数据,7632例患者(3568例接受SK治疗,4064例对照患者)可得出可接受的CK曲线。与对照组(图1 - 表I)相比,接受SK治疗的患者Ki和Kd值升高,To降低(p>0.001),Dp/Ki降低(p>0.05)。SK治疗开始得越早,两组(SK和C)之间观察到的差异越大(图2)。在性别(图3)、年龄、既往心肌梗死病史、再梗死、梗死早期心绞痛方面,两组(SK和C)之间未发现显著差异。当考虑不同梗死部位时,SK组和C组之间上述参数在统计学上也存在显著相似差异,但非Q波梗死除外(图4)。在并发心包炎的病例中(表II,图5),无论治疗如何,均观察到再灌注相关指标降低,Dp/Ki比值升高。严重左心室功能不全(Killip 4级)倾向于缩小两组(SK和C)之间酶参数的差异(表III)。与幸存者相比,死亡患者(症状发作后18小时)唯一显著不同的是与梗死面积相关的CK参数(Dp/Ki),与治疗无关。本研究中使用的数学模型被证明易于实施,且对评估急性心肌梗死治疗效果有用。(摘要截选至400字)